دورية أكاديمية
MicroRNA-335-5p suppresses voltage-gated sodium channel expression and may be a target for seizure control.
| العنوان: | MicroRNA-335-5p suppresses voltage-gated sodium channel expression and may be a target for seizure control. |
|---|---|
| المؤلفون: | Heiland M; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland.; FutureNeuro Science Foundation Ireland Research Centre, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland., Connolly NMC; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland.; FutureNeuro Science Foundation Ireland Research Centre, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland., Mamad O; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland.; FutureNeuro Science Foundation Ireland Research Centre, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland., Nguyen NT; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland.; FutureNeuro Science Foundation Ireland Research Centre, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland., Kesavan JC; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland.; FutureNeuro Science Foundation Ireland Research Centre, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland., Langa E; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland.; FutureNeuro Science Foundation Ireland Research Centre, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland., Fanning K; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland.; FutureNeuro Science Foundation Ireland Research Centre, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland., Sanfeliu A; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland.; FutureNeuro Science Foundation Ireland Research Centre, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland., Yan Y; Interdisciplinary Nanoscience Centre, Aarhus University, 8000 Aarhus C, Denmark.; Department of Molecular Biology and Genetics, Aarhus University, 8000 Aarhus C, Denmark.; Omiics, 8200 Aarhus N, Denmark., Su J; Interdisciplinary Nanoscience Centre, Aarhus University, 8000 Aarhus C, Denmark.; Department of Molecular Biology and Genetics, Aarhus University, 8000 Aarhus C, Denmark., Venø MT; Interdisciplinary Nanoscience Centre, Aarhus University, 8000 Aarhus C, Denmark.; Department of Molecular Biology and Genetics, Aarhus University, 8000 Aarhus C, Denmark.; Omiics, 8200 Aarhus N, Denmark., Costard LS; Epilepsy Center, Department of Neurology, Philipps University Marburg, Marburg 35043, Germany.; Epilepsy Center Frankfurt Rhine-Main, Department of Neurology, University Hospital Frankfurt, Frankfurt a.M. 60528, Germany.; Landes-Offensive zur Entwicklung Wissenschaftlich-ökonomischer Exzellenz, Center for Personalized Translational Epilepsy Research, Goethe-University Frankfurt, Frankfurt a.M. 60528, Germany., Neubert V; Epilepsy Center, Department of Neurology, Philipps University Marburg, Marburg 35043, Germany., Engel T; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland.; FutureNeuro Science Foundation Ireland Research Centre, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland., Hill TDM; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland.; FutureNeuro Science Foundation Ireland Research Centre, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland., Freiman TM; Epilepsy Center Frankfurt Rhine-Main, Department of Neurology, University Hospital Frankfurt, Frankfurt a.M. 60528, Germany.; Department of Neurosurgery, University of Rostock, Rostock 18057, Germany., Mahesh A; Institute of Molecular Medicine, University of Southern Denmark, 5000 Odense, Denmark., Tiwari VK; Institute of Molecular Medicine, University of Southern Denmark, 5000 Odense, Denmark.; Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Science, Queens University, Belfast BT9 7BL, United Kingdom.; Danish Institute for Advanced Study, University of Southern Denmark, 5230 Odense, Denmark.; Department of Clinical Genetics, Odense University Hospital, 5000 Odense, Denmark., Rosenow F; Epilepsy Center, Department of Neurology, Philipps University Marburg, Marburg 35043, Germany.; Epilepsy Center Frankfurt Rhine-Main, Department of Neurology, University Hospital Frankfurt, Frankfurt a.M. 60528, Germany.; Landes-Offensive zur Entwicklung Wissenschaftlich-ökonomischer Exzellenz, Center for Personalized Translational Epilepsy Research, Goethe-University Frankfurt, Frankfurt a.M. 60528, Germany., Bauer S; Epilepsy Center, Department of Neurology, Philipps University Marburg, Marburg 35043, Germany.; Epilepsy Center Frankfurt Rhine-Main, Department of Neurology, University Hospital Frankfurt, Frankfurt a.M. 60528, Germany.; Landes-Offensive zur Entwicklung Wissenschaftlich-ökonomischer Exzellenz, Center for Personalized Translational Epilepsy Research, Goethe-University Frankfurt, Frankfurt a.M. 60528, Germany., Kjems J; Interdisciplinary Nanoscience Centre, Aarhus University, 8000 Aarhus C, Denmark.; Department of Molecular Biology and Genetics, Aarhus University, 8000 Aarhus C, Denmark., Morris G; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland.; FutureNeuro Science Foundation Ireland Research Centre, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland.; Department of Neuroscience, Physiology and Pharmacology, University College London, London WC1E 6BT, United Kingdom., Henshall DC; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland.; FutureNeuro Science Foundation Ireland Research Centre, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland. |
| المصدر: | Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2023 Jul 25; Vol. 120 (30), pp. e2216658120. Date of Electronic Publication: 2023 Jul 18. |
| نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Washington, DC : National Academy of Sciences |
| مواضيع طبية MeSH: | Induced Pluripotent Stem Cells*/metabolism , Epilepsy* , MicroRNAs*/genetics , MicroRNAs*/metabolism , Voltage-Gated Sodium Channels*/genetics, Humans ; Mice ; Rats ; Animals ; Seizures/chemically induced ; Seizures/genetics ; Seizures/metabolism ; NAV1.1 Voltage-Gated Sodium Channel/genetics ; NAV1.1 Voltage-Gated Sodium Channel/metabolism ; NAV1.3 Voltage-Gated Sodium Channel/genetics |
| مستخلص: | There remains an urgent need for new therapies for treatment-resistant epilepsy. Sodium channel blockers are effective for seizure control in common forms of epilepsy, but loss of sodium channel function underlies some genetic forms of epilepsy. Approaches that provide bidirectional control of sodium channel expression are needed. MicroRNAs (miRNA) are small noncoding RNAs which negatively regulate gene expression. Here we show that genome-wide miRNA screening of hippocampal tissue from a rat epilepsy model, mice treated with the antiseizure medicine cannabidiol, and plasma from patients with treatment-resistant epilepsy, converge on a single target-miR-335-5p. Pathway analysis on predicted and validated miR-335-5p targets identified multiple voltage-gated sodium channels (VGSCs). Intracerebroventricular injection of antisense oligonucleotides against miR-335-5p resulted in upregulation of Scn1a , Scn2a , and Scn3a in the mouse brain and an increased action potential rising phase and greater excitability of hippocampal pyramidal neurons in brain slice recordings, consistent with VGSCs as functional targets of miR-335-5p. Blocking miR-335-5p also increased voltage-gated sodium currents and SCN1A, SCN2A , and SCN3A expression in human induced pluripotent stem cell-derived neurons. Inhibition of miR-335-5p increased susceptibility to tonic-clonic seizures in the pentylenetetrazol seizure model, whereas adeno-associated virus 9-mediated overexpression of miR-335-5p reduced seizure severity and improved survival. These studies suggest modulation of miR-335-5p may be a means to regulate VGSCs and affect neuronal excitability and seizures. Changes to miR-335-5p may reflect compensatory mechanisms to control excitability and could provide biomarker or therapeutic strategies for different types of treatment-resistant epilepsy. |
| التعليقات: | Comment in: Epilepsy Curr. 2023 Nov 22;24(1):50-52. (PMID: 38327537) |
| References: | Sci Rep. 2015 Jul 24;5:12448. (PMID: 26207921) Neurobiol Dis. 2019 Oct;130:104508. (PMID: 31212067) Proc Natl Acad Sci U S A. 2020 Jul 7;117(27):15977-15988. (PMID: 32581127) Science. 2017 May 26;356(6340):. (PMID: 28495876) Bioinformatics. 2016 Sep 15;32(18):2847-9. (PMID: 27207943) Biosci Rep. 2016 Dec 23;36(6):. (PMID: 27852797) Neurochirurgie. 2022 Dec;68(6):583-588. (PMID: 35700789) Eur J Neurosci. 2017 Sep;46(5):2121-2132. (PMID: 28715131) J Physiol. 1952 Aug;117(4):500-44. (PMID: 12991237) Nucleic Acids Res. 2022 Jan 7;50(D1):D211-D221. (PMID: 34570238) Lancet Neurol. 2010 Apr;9(4):413-24. (PMID: 20298965) Trends Pharmacol Sci. 2021 Jul;42(7):605-616. (PMID: 33992468) J Cell Biol. 2013 Jul 8;202(1):53-69. (PMID: 23836929) Nucleic Acids Res. 2019 Jan 8;47(D1):D155-D162. (PMID: 30423142) CNS Drugs. 2021 Sep;35(9):935-963. (PMID: 34145528) Cell Rep. 2016 Sep 27;17(1):37-45. (PMID: 27681419) Nucleic Acids Res. 2018 Jan 4;46(D1):D239-D245. (PMID: 29156006) Biochem Biophys Res Commun. 2016 Dec 2;481(1-2):13-18. (PMID: 27833019) Front Neurosci. 2016 Nov 09;10:519. (PMID: 27881950) Nat Med. 2012 Jul;18(7):1087-94. (PMID: 22683779) Nat Neurosci. 2006 Sep;9(9):1142-9. (PMID: 16921370) CNS Drugs. 2017 Jul;31(7):527-534. (PMID: 28523600) Nucleic Acids Res. 2016 May 5;44(8):3865-77. (PMID: 26921406) Nat Struct Mol Biol. 2013 Dec;20(12):1434-42. (PMID: 24213538) Epilepsia Open. 2022 Aug;7 Suppl 1:S8-S22. (PMID: 35253410) PLoS One. 2013 Oct 11;8(10):e76051. (PMID: 24146813) OMICS. 2012 May;16(5):284-7. (PMID: 22455463) Epilepsy Res. 1987 Sep;1(5):302-5. (PMID: 3504406) Curr Treat Options Neurol. 2018 Oct 13;20(12):52. (PMID: 30315507) Mol Med Rep. 2018 Jan;17(1):1375-1381. (PMID: 29115566) Science. 2013 Dec 6;342(6163):1254-8. (PMID: 24311694) Front Mol Neurosci. 2015 Oct 13;8:59. (PMID: 26528124) Neurobiol Learn Mem. 2017 Mar;139:63-68. (PMID: 28039088) Nucleic Acids Res. 2018 Jan 4;46(D1):D296-D302. (PMID: 29126174) Nat Rev Neurol. 2020 Sep;16(9):506-519. (PMID: 32546757) Eur J Paediatr Neurol. 2020 Jan;24:129-133. (PMID: 31928904) Physiol Rev. 2021 Oct 1;101(4):1633-1689. (PMID: 33769100) Curr Neurol Neurosci Rep. 2018 Jul 25;18(9):60. (PMID: 30046905) Nucleic Acids Res. 2019 Jan 8;47(D1):D948-D954. (PMID: 30247620) Nat Rev Neurosci. 2021 Mar;22(3):152-166. (PMID: 33531663) Sci Rep. 2021 May 6;11(1):9649. (PMID: 33958654) Proc Natl Acad Sci U S A. 2021 Nov 23;118(47):. (PMID: 34785595) Sci Rep. 2017 Sep 14;7(1):11592. (PMID: 28912503) Seizure. 2017 Jan;44:11-20. (PMID: 28007376) J Neurosci Methods. 2011 Jan 30;195(1):15-23. (PMID: 21075142) Mol Brain. 2020 Aug 21;13(1):114. (PMID: 32825833) Proc Natl Acad Sci U S A. 2017 Jun 20;114(25):E4996-E5005. (PMID: 28584127) Nucleic Acids Res. 2018 Jan 4;46(D1):D360-D370. (PMID: 29194489) Hippocampus. 2010 Apr;20(4):492-8. (PMID: 19557767) J Pharmacol Exp Ther. 2010 Feb;332(2):569-77. (PMID: 19906779) Nat Rev Drug Discov. 2020 Oct;19(10):673-694. (PMID: 32782413) Electroencephalogr Clin Neurophysiol. 1972 Mar;32(3):281-94. (PMID: 4110397) eNeuro. 2017 Dec 28;4(6):. (PMID: 29291240) Oncogene. 2010 Apr 15;29(15):2161-4. (PMID: 20190803) Cell. 2008 Jan 11;132(1):9-14. (PMID: 18191211) J Mol Neurosci. 2019 Dec;69(4):580-587. (PMID: 31368064) Mol Ther Nucleic Acids. 2022 Apr 20;28:514-529. (PMID: 35592499) PLoS One. 2012;7(5):e35921. (PMID: 22615744) Neuropsychiatr Dis Treat. 2014 Sep 09;10:1693-705. (PMID: 25228809) J Physiol. 2023 May;601(10):1711-1718. (PMID: 36949604) Expert Rev Neurother. 2020 Oct;20(10):1065-1079. (PMID: 32799683) EBioMedicine. 2018 Dec;38:127-141. (PMID: 30396857) Epilepsia. 2010 Apr;51(4):686-9. (PMID: 20074235) Epilepsia. 2017 Nov;58(11):1807-1816. (PMID: 28880996) Neurosci Lett. 2015 Oct 8;606:167-72. (PMID: 26314506) Cell. 2004 Jan 23;116(2):281-97. (PMID: 14744438) Epilepsia. 2014 Apr;55(4):475-82. (PMID: 24730690) Mol Biosyst. 2016 Feb;12(2):477-9. (PMID: 26661513) Curr Protoc Microbiol. 2013;Chapter 14:14D.5.1-14D.5.18. (PMID: 23686825) Eur J Neurosci. 2010 Mar;31(6):1100-7. (PMID: 20214679) Neurobiol Dis. 2014 Feb;62:508-20. (PMID: 24184920) Int J Mol Med. 2019 Mar;43(3):1452-1466. (PMID: 30747210) Nat Struct Mol Biol. 2010 Jul;17(7):909-15. (PMID: 20601959) Am J Pathol. 2011 Nov;179(5):2519-32. (PMID: 21945804) Elife. 2015 Aug 12;4:. (PMID: 26267216) |
| معلومات مُعتمدة: | United Kingdom WT_ Wellcome Trust |
| فهرسة مساهمة: | Keywords: adeno-associated virus; antisense oligonucleotides; drug resistance; epilepsy; noncoding RNA |
| المشرفين على المادة: | 0 (MicroRNAs) 0 (Voltage-Gated Sodium Channels) 0 (MIRN335 microRNA, human) 0 (Scn1a protein, mouse) 0 (NAV1.1 Voltage-Gated Sodium Channel) 0 (Mirn335 microRNA, mouse) 0 (Scn3a protein, rat) 0 (NAV1.3 Voltage-Gated Sodium Channel) |
| تواريخ الأحداث: | Date Created: 20230718 Date Completed: 20230721 Latest Revision: 20240208 |
| رمز التحديث: | 20240208 |
| مُعرف محوري في PubMed: | PMC10372546 |
| DOI: | 10.1073/pnas.2216658120 |
| PMID: | 37463203 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1091-6490 |
|---|---|
| DOI: | 10.1073/pnas.2216658120 |